Phibro Animal Health Co. (NASDAQ:PAHC) Given Consensus Recommendation of "Reduce" by Brokerages

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) has earned an average recommendation of "Reduce" from the five brokerages that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $20.80.

A number of brokerages have commented on PAHC. Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target for the company in a research report on Monday. Finally, Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Nuveen LLC acquired a new stake in Phibro Animal Health in the first quarter valued at $10,312,000. Invesco Ltd. raised its stake in Phibro Animal Health by 92.3% in the first quarter. Invesco Ltd. now owns 387,739 shares of the company's stock valued at $8,282,000 after buying an additional 186,087 shares in the last quarter. Axecap Investments LLC acquired a new stake in Phibro Animal Health in the first quarter valued at $3,696,000. Millennium Management LLC raised its stake in Phibro Animal Health by 74.3% in the first quarter. Millennium Management LLC now owns 362,030 shares of the company's stock valued at $7,733,000 after buying an additional 154,281 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its position in shares of Phibro Animal Health by 56.7% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock worth $6,325,000 after purchasing an additional 108,918 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Trading Down 0.4%

NASDAQ PAHC opened at $24.41 on Monday. The firm has a market capitalization of $989.23 million, a PE ratio of 49.85, a P/E/G ratio of 0.45 and a beta of 0.74. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health has a twelve month low of $16.16 and a twelve month high of $26.55. The stock's 50 day moving average is $21.25 and its 200 day moving average is $21.88.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts forecast that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be issued a $0.12 dividend. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.97%. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.